ZOM: Next target and Key Points (UPDATED)!Hello traders and investors! Let’s talk about ZOM again! It has been nearly one month since my last analysis, so, let’s see if it behaved accordingly to our logic. My previous analysis was public, and the link to it is below this post, as always.
First, the green line at $ 2.34 worked as a support, thanks to the Principle of Polarity, which we already discussed, and then it lost the support level at $ 2.13, and it just sought for the next support level.
It hit the support we were aiming in my last analysis at $ 1.48, and since then ZOM is reacting very well, as it is finally doing Higher highs/higher lows , a trait of a short-term bull trend in the 1h chart.
The daily chart is looking good too:
Here we see clearly how ZOM respected the $ 1.48, as it did very long shadows under the candlestick’s bodies every time it hit there. Clearly, there was a lot of buy force around this support. I only wish the volume to be higher.
We said that pullbacks to this level would only offer an opportunity to buy, and ZOM did it twice.
Since the beginning the odds were in the favor of the bulls. Now if ZOM defeats the $ 2.25 the next target will be the $ 2.90, as it would trigger a Double Bottom chart pattern. But I believe now it is not the time to buy ZOM, as the moment has passed. The good time to buy was near the $ 1.48. Remember, always buy near support levels.
Now is time to manage positions and keep our eyes in the $ 2.25. And if you liked this analysis, remember to follow me to keep in touch with my daily studies, and support this idea if you liked it!
Thank you very much. Have a nice weekend.
ZOM
SOS Get Out Immediately!!Just as many other symbols are going up and completing blow off tops with evening stars, here is another one. SOS has went up about 400% within 4 day with a major gap and gap down to end the move with an evening star. The target is about $4.50, which is the 1.618 fib extension level of the first leg down and also the structure area of the break out. The move should be quick and swift.
Is CCIV a buy?CCIV yesterday was majorly sold off then making a V-shaped recovery. It now shows a triangulation pattern, which may indicate a breakout. Overall you should check out CCIV for some potential Buy opportunities. Rsi close to oversold. Warning! I am not a financial adviser and take this with a grain of salt. Happy trading!
ZOM: Should we panic-sell this now?Hello traders and investors! Let’s talk about ZOM today, and do our usual Multi Time Frame Analysis (MTFA)!
First, let’s start with the 1h chart. ZOM did a classic Double Top chart pattern at $ 2.91 (black line), and now it is dropping to its support levels. The first support lost, after some fight, was the 21 ema. Then the green line at $ 2.34, and now it is trying to lose the blue line at $ 2.13 as well. Since it is a short-term bear trend, ZOM will keep seeking for lower supports, until one works and holds the price.
What’s more, according to the Principle or Polarity , when a support is lost, it is supposed to work as a resistance next, and vice-versa. The green line and the 21 ema could make a strong resistance zone for ZOM in the short-term. Also, keep in mind that ZOM lost the green line by doing a Gap , which is also going to work as a resistance.
The fight is not going to be easy for ZOM, but let’s see if the daily chart has something else to tell us:
In the mid-term, the trend is clearly bullish, and in a bull trend, pullbacks are expected and seen as opportunities to buy.
We have a strong support area between the 21 ema, the black line at $ 1.48 (previous top) and the Gap (yellow rectangle), and ZOM could retest again this area and the trend would still be bullish.
What is interesting is the volume , as it increases during upside movements, and decreases when the stock drops or enters in a congestion, meaning that the buy force is stronger than the sell force at this moment.
And if you liked this analysis, remember to follow me to keep in touch with my daily updates. And support this idea if it helped you! Let's wait for more confirmation on the charts, before jumping into any conclusion regarding ZOM.
Thank you very much,
ZOM - For the next few days, the price will make an accumulation channel between 2.05 and 2.50.
If it breaks the lower limit of the channel, then it will go to the monthly support of 1.83.
For short term transactions you can enter buy (only buy, not sell !!) at the lower limit of the channel. If it breaks the lower limit of the channel, then it will go to the monthly support of 1.83. But don't close the position!
For long term it is ideal to enter at 1.83 for a rise of 65% to 3.00 where it will make a small pullback and then break the monthly resistance of 3.00 to a value of 4.50 - 5.00
AMEX:ZOM
$ZOM could surge 100% due to upcoming launch of TruformaTangible catalyst behind surge is due to the upcoming launch of Truforma , Zomedica’s point-of-care (POC) diagnostic device for the detection of thyroid disease in dogs and cats and adrenal disease in dogs.
The platform will hit the market on March 30 , and ahead of the product’s debut, the company has also just nabbed a vital distribution deal.
Last week, Zomedica announced an agreement with Miller Veterinary Supply who will distribute Truforma.
Miller is the U.S.’s oldest wholesale veterinary distributor and one of the veterinary industry’s fastest growing businesses. The company will be Zomedica’s representative in the eastern and mid-eastern states. Its sales and customer service efforts will be bolstered by sales representatives assigned by Zomedica, which the company is currently recruiting as it prepares for the launch.
The pet market has been a prime beneficiary of the pandemic’s stay-at-home mandates and according to the American Pet Products Association, spending in the segment reached a record $99 billion in the U.S. last year. Outlay on diagnostic care in this market is expected to grow to $2.8 billion in 2024 from $1.7 billion in 2019.
H.C. Wainwright analyst Swayampakula Ramakanth says that ahead of Truforma’s debut, the agreement “strengthens the commercial machinery.”
“We are encouraged by the progress in commercial preparation for the upcoming launch, and accordingly we are raising the probability of launch to 90%, up from 75% previously,” the 5-star analyst said. “Additionally, due to the lower yield of the long-term Treasury note that has resulted in a lower risk-free rate and a lower market risk premium, we have adjusted the discount rate to 6% from 12%.”
To this end, Ramakanth boosted his price target on ZOM from $0.3 to $1.2, suggesting upside of an additional 20% from current levels. Needless to say, Ramakanth’s rating stays a Buy.
finance.yahoo.com
ZOMEDICA CORP STOCK Analysis Technical Analysis
The Idea is to go long following the Major trend: Option 1: if 2.00 USD resistance will not be broken -
Wait the end of a possible price retracement before going log (it might go down to 1.45 USD)
Option 2: if 2.00 USD resistance will be broken in the next days, go long aiming to reach Target Price 1 and then 2.
Fundamental Analysis
The veterinary health specialist is slated to launch its patented Truforma diagnostic system on March 30. The platform is designed to produce fast and accurate results when used to detect diseases in dogs and cats.
The Idea is to go long following the Major trend: Option 1: if 2.00 USD resistance will not be broken -
Wait the end of a possible price retracement before going log (it might go down to 1.45 USD)
Option 2: if 2.00 USD resistance will be broken in the next days, go long aiming to reach Target Price 1 and then 2.
AMEX:ZOM
ZOMEDICA 30% Short LETS SQUEEZE! PT $6!Zomedica Corp. is on the road back to it’s ATH.
Easy Hold with a lot of Upside into the New Year
Truforma will be released in April 2021!!!
February Earning will include Preorders of Truforma Sales
Ex CEO of Pfizer is our New CEO
He Pushed Out Viagra Back in the Day
Ex Vice President of IDEXX is on the Zomedica board also holding 600,000 shares at 16 Cents
Board Members, Owners, Works, Banks
JP Morgan, Morgan Stanley, Cambridge Are In!
Has a lot upswing going into 2021 Even More LT
Remember Big Guns can’t go to hard in accumulation it’s not allowed by most institutions and banks. Because it’s under $1 they like stocks that are in the $5 range but as soon as we are in the dollar range which is closer to March a lot PR will be released by their team to skyrocket this to $5+!!!
$IDEXX $400+
$ZTS MERGER RUMORS
$QRVO $150+ Zomedica’s Partner in Truforma
Make sure your not lending your shares to shorts!!! This about all your investments!!! Check with your Broker!!! Very Important!!!
$ZOM will be $1+ April 2021
it’s under 25 Cents a Share
Always Do Your Own DD Guys!!!
The verified Facts: TRUFORMA Commercialization announced for March 2021, domestication & R/S denied, we have forced their hand and are secure Long Term, lawsuit working towards mediation in another 2-11 months, internal launch team complete,70 pending & approved patents, 5 Assays, pending validations and FDA approvals, Qorvo Partnership, Bulk Acoustic Wave (“BAW”) technology, Projected $2.8 billion industry, believed to be the first ever for use at the point-of-care and the first ever available in veterinary medicine, latest find is new career openings for (professional services veterinarian, territory diagnostic specialist, and scientist).
Zomedica Upcoming TRUFORMA™ on March 30, 2021Protected by approximately 70 issued and pending patents, the TRUFORMA diagnostic platform uses Bulk Acoustic Wave (“BAW”) technology, developed by Qorvo (NASDAQ: QRVO), to provide a non-optical and fluorescence-free detection system for use at the point-of-care.
BAW technology, also used in cell phones and in the world’s most advanced radar and communications systems, is an extremely reliable and precise technology.
Zomedica expects to begin commercial sales of TRUFORMA on March 30, 2021.
Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians.
Zomedica’s product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. (source: globenewswire.com)
Please leave me a message if you want to test the buy and sell indicators that i am using.
BIG ZOM BIG DREAMStoo many peoples is coming here tlaking about tings like charts and patturns but what about the stuff that matters
let me tell you a story of a little company that saids, hey lets makes the stuff for peeps to treat animal rite? eya
too many companie pushing theories and research with no practicals use. they publish all this stuffs but where da cheese? where da bidness acumen? where da practic to da theori?
well my frens this where tha zom is comin
dey gots tha lemons and tha juice, so dont come crying to mama when ya magic charts did ya dirty. go looky looky at der product about to make lunch in 2021. with that kind of design dey be flying off tha shelves, i call all my ventrilnatina animal frens and say, yo bruhzuwala yo geetin tha zomedica stufsfs and of course they sday "AHA OH YEAH BABYCAKES HYUCK DUHAH WE GOOFY FO DAT SHIZ"
if you hav been followin my smart guide u made millions off natilus and lost it all on tesla puts. now its time to take that 0 and multiply it by 10x to take home da big bux with a nice ZOM sanwich.
SPECIAL NOTE: wall street bets autists will be talking about this stonk soon so buy before they do!!!!11111